These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17763059)

  • 41. BCP ceramic microspheres as drug delivery carriers: synthesis, characterisation and doxycycline release.
    Victor SP; Kumar TS
    J Mater Sci Mater Med; 2008 Jan; 19(1):283-90. PubMed ID: 17597367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and characterization of gelatin nanoparticles using CDI/NHS as a non-toxic cross-linking system.
    Qazvini NT; Zinatloo S
    J Mater Sci Mater Med; 2011 Jan; 22(1):63-9. PubMed ID: 21052793
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The concentration of the cross-linking agent as a tool for the control of release and swelling properties of gelatin microspheres.
    Vandelli MA; Forni F; Iannuccelli V; Cameroni R
    J Pharm Belg; 1991; 46(6):381-8. PubMed ID: 1783972
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of process variables on particle size of gelatin microspheres containing lactic acid.
    Dinarvand R; Mahmoodi S; Farboud E
    Pharm Dev Technol; 2004 Aug; 9(3):291-9. PubMed ID: 15458234
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modeling of small-molecule release from crosslinked hydrogel microspheres: effect of crosslinking and enzymatic degradation of hydrogel matrix.
    Cheng F; Choy YB; Choi H; Kim KK
    Int J Pharm; 2011 Jan; 403(1-2):90-5. PubMed ID: 20971173
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis of gelatin microspheres containing interferon.
    Tabata Y; Ikada Y
    Pharm Res; 1989 May; 6(5):422-7. PubMed ID: 2473465
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Comparison of Two Methods for the Preparation Cefquinome-Loaded Gelatin Microspheres for Lung Targeting.
    Qu S; Dai C; Yang F; Huang T; Xu T; Zhao L; Li Y; Hao Z
    Pharm Res; 2018 Feb; 35(2):43. PubMed ID: 29404707
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparation and characterization of a biodegradable drug targeting system for anticancer drug delivery: microsphere-antibody conjugate.
    Muvaffak A; Gurhan I; Gunduz U; Hasirci N
    J Drug Target; 2005 Apr; 13(3):151-9. PubMed ID: 16036303
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparation of porcine small intestinal submucosa sponge and their application as a wound dressing in full-thickness skin defect of rat.
    Kim MS; Hong KD; Shin HW; Kim SH; Kim SH; Lee MS; Jang WY; Khang G; Lee HB
    Int J Biol Macromol; 2005 Jul; 36(1-2):54-60. PubMed ID: 15939465
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro release of lysozyme from gelatin microspheres: effect of cross-linking agents and thermoreversible gel as suspending medium.
    Hiwale P; Lampis S; Conti G; Caddeo C; Murgia S; Fadda AM; Monduzzi M
    Biomacromolecules; 2011 Sep; 12(9):3186-93. PubMed ID: 21809827
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gelatin methacrylate microspheres for controlled growth factor release.
    Nguyen AH; McKinney J; Miller T; Bongiorno T; McDevitt TC
    Acta Biomater; 2015 Feb; 13():101-10. PubMed ID: 25463489
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of solvent composition on the performance of carbodiimide cross-linked gelatin carriers for retinal sheet delivery.
    Lai JY
    J Mater Sci Mater Med; 2013 Sep; 24(9):2201-10. PubMed ID: 23677435
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimized protocol for protein macrocomplexes stabilization using the EDC, 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide, zero-length cross-linker.
    Lepvrier E; Doigneaux C; Moullintraffort L; Nazabal A; Garnier C
    Anal Chem; 2014 Nov; 86(21):10524-30. PubMed ID: 25268573
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cross-linked collagen sponges loaded with plant polyphenols with inhibitory activity towards chronic wound enzymes.
    Antonio F; Guillem R; Sonia T; Clara M; Piergiorgio G; Valeria C; Gianluca C; Tzanov T
    Biotechnol J; 2011 Oct; 6(10):1208-18. PubMed ID: 21805643
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The properties of chitosan-gelatin membranes and scaffolds modified with hyaluronic acid by different methods.
    Mao JS; Liu HF; Yin YJ; Yao KD
    Biomaterials; 2003 Apr; 24(9):1621-9. PubMed ID: 12559822
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biocompatibility and biodegradation of cross-linked gelatin/hyaluronic acid sponge in rat subcutaneous tissue.
    Hong SR; Chong MS; Lee SB; Lee YM; Song KW; Park MH; Hong SH
    J Biomater Sci Polym Ed; 2004; 15(2):201-14. PubMed ID: 15109098
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carbodiimide cross-linking inactivates soluble and matrix-bound MMPs, in vitro.
    Tezvergil-Mutluay A; Mutluay MM; Agee KA; Seseogullari-Dirihan R; Hoshika T; Cadenaro M; Breschi L; Vallittu P; Tay FR; Pashley DH
    J Dent Res; 2012 Feb; 91(2):192-6. PubMed ID: 22058118
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of drug loading level on drug release and dynamic swelling of crosslinked gelatin microspheres.
    Forni F; Vandelli MA; Cameroni R
    J Microencapsul; 1992; 9(1):29-39. PubMed ID: 1613641
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glutaraldehyde cross-linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: studies on the in vitro release of mitoxantrone and in vivo degradation of microspheres in rat muscle.
    Jameela SR; Jayakrishnan A
    Biomaterials; 1995 Jul; 16(10):769-75. PubMed ID: 7492707
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mineralization, biodegradation, and drug release behavior of gelatin/apatite composite microspheres for bone regeneration.
    Leeuwenburgh SC; Jo J; Wang H; Yamamoto M; Jansen JA; Tabata Y
    Biomacromolecules; 2010 Oct; 11(10):2653-9. PubMed ID: 20804200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.